Literature DB >> 23413664

Body mass index of inpatients with schizophrenia in Japan.

Yukiko Inamura1, Toyoaki Sagae, Kenichi Nakamachi, Nobuko Murayama.   

Abstract

OBJECTIVE: Many studies reported that obesity rate in the Western countries is higher in schizophrenia patients than in general population. In this study, we surveyed nationwide Body Mass Index (BMI) status of hospitalized Japanese schizophrenia patients.
METHODS: Subjects included 15,171 patients (7,897 men and 7,274 women) hospitalized for schizophrenia, who were sampled from all 47 administrative divisions in Japan. The BMI data of these patients were compared to those of the general population in the 2009 National Health and Nutrition Survey conducted by the Japanese Ministry of Health.
RESULTS: The median BMI value in the patients was 21.6 kg/m2 (first quartile, 19.1; third quartile, 24.5). The percentages of BMI in obese, normal-weight, and underweight patients were 21.6%, 58.2%, and 20.2%, respectively. In the Japanese male patients, frequency of obesity was lower, and underweight was higher than those in the general population. In female patients, frequency of both obesity and underweight were higher than those in the general population.
CONCLUSIONS: Our results provided evidence that underweight as well as obesity is a characteristic in Japanese schizophrenia inpatients.

Entities:  

Mesh:

Year:  2012        PMID: 23413664     DOI: 10.2190/PM.44.2.h

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  7 in total

1.  The prevalence and independent influencing factors of obesity and underweight in patients with schizophrenia: a multicentre cross-sectional study.

Authors:  Juan Wang; Yulong Zhang; Yating Yang; Zhiwei Liu; Lei Xia; Wenzheng Li; Zhongxiang Li; Xinhui Xie; Wenfeng Deng; Kai Zhang; Huanzhong Liu
Journal:  Eat Weight Disord       Date:  2020-06-17       Impact factor: 4.652

2.  Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders: A Genome-wide Association Study.

Authors:  Shahram Bahrami; Nils Eiel Steen; Alexey Shadrin; Kevin O'Connell; Oleksandr Frei; Francesco Bettella; Katrine V Wirgenes; Florian Krull; Chun C Fan; Anders M Dale; Olav B Smeland; Srdjan Djurovic; Ole A Andreassen
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

3.  Homozygous Deletion of Glutathione Peroxidase 1 and Aldehyde Dehydrogenase 1a1 Genes Is Not Associated with Schizophrenia-Like Behavior in Mice.

Authors:  Xiang Bai; Elizabeth Fermandez; Georgianna Gould; Randy Strong
Journal:  J Biochem Pharmacol Res       Date:  2013-12-01

4.  4G-β-D-galactosylsucrose as a prebiotics may improve underweight in inpatients with schizophrenia.

Authors:  Takahiko Nagamine; Yumiko Ido; Masaru Nakamura; Takehiko Okamura
Journal:  Biosci Microbiota Food Health       Date:  2018-01-06

5.  High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey.

Authors:  Shin Ono; Takuro Sugai; Yutaro Suzuki; Manabu Yamazaki; Kazutaka Shimoda; Takao Mori; Yuji Ozeki; Hiroshi Matsuda; Norio Sugawara; Norio Yasui-Furukori; Kurefu Okamoto; Toyoaki Sagae; Toshiyuki Someya
Journal:  BMC Psychiatry       Date:  2018-06-08       Impact factor: 3.630

6.  Exploring Lead loci shared between schizophrenia and Cardiometabolic traits.

Authors:  Qian He; Adam N Bennett; Jundong Liu; Beifang Fan; Xue Han; Lu Cheng; Yan Chen; Xia Yang; Kei Hang Katie Chan
Journal:  BMC Genomics       Date:  2022-08-25       Impact factor: 4.547

7.  High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey.

Authors:  Takuro Sugai; Yutaro Suzuki; Manabu Yamazaki; Kazutaka Shimoda; Takao Mori; Yuji Ozeki; Hiroshi Matsuda; Norio Sugawara; Norio Yasui-Furukori; Yoshitake Minami; Kurefu Okamoto; Toyoaki Sagae; Toshiyuki Someya
Journal:  BMJ Open       Date:  2015-12-09       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.